Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preservation After Tooth Extraction
Condition(s) studied
Investigational drug(s) / intervention(s)
Gel foam: Patients will receive gel foam only.
Thymoquinone gel + gel foam: Patients will receive 0.2% thymoquinone gel + gel foam.
Nano-formulated 0.2% thymoquinone gel + gel foam: Patients will receive nano-formulated 0.2% thymoquinone gel + gel foam.
Study summary
This study aims to evaluate the clinical and radiographic effects of 0.2% Thymoquinone gel on bone density, bone width, and socket preservation after tooth extraction.
Eligibility
Primary outcome measure(s)
- Change in alveolar bone density after tooth extraction — 3 months after tooth extraction
Alveolar bone density will be assessed radiographically using cone-beam computed tomography (CBCT). The change in bone density from baseline to the specified postoperative assessment will be compared.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Kafrelsheikh University | Kafr ash Shaykh | Kafrelsheikh | Recruiting |
More Kafrelsheikh University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07765745 on ClinicalTrials.gov ↗ ← All trials in Egypt